Understanding clinical significance, and the new epinephrine nasal spray
In this podcast accompanying the March 2026 issue of the DTB (https://dtb.bmj.com/content/64/3), Syba Sunny (DTB Clinical Editor) is joined...
Radio and PodcastLive Radio & PodcastsScience & Medicine
DTB podcast
For 50 years, Drug and Therapeutics Bulletin (DTB) has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease...
Episodes
20 of 188 episodesGLP-1 drugs, reducing sedative use, and a thank you
In this podcast accompanying the February 2026 issue of the DTB ( https://dtb.bmj.com/content/64/2 ), Syba Sunny (DTB Clinical Editor) is jo...
Disinformation and misinformation, AI in primary care and antidepressant tapering
In this podcast accompanying the January 2026 issue of the DTB ( https://dtb.bmj.com/content/64/1 ), Syba Sunny (DTB Clinical Editor) is joi...
Prevention in primary care, elinzanetant for menopause, and a farewell to David.
In this podcast accompanying the December issue of the DTB ( https://dtb.bmj.com/content/63/12 ), David Phizackerley (DTB Editor) is joined...
Medicines - but at what cost, direct penicillin allergy challenge, and prescribing mistakes
In this podcast accompanying the November issue of DTB ( https://dtb.bmj.com/content/63/11 ) David Phizackerley (DTB Editor) is joined by Sy...
Orphan drugs, allopurinol and CVD, mavacamten for obstructive hypertrophic cardiomyopathy
In this podcast accompanying the October issue of DTB ( https://dtb.bmj.com/content/63/10 ) David Phizackerley (DTB Editor) is joined by Jul...
Antibiotic susceptibility reports, deprescribing, and heart failure drugs
In this podcast accompanying the September issue of DTB ( https://dtb.bmj.com/content/63/9 ), David Phizackerley (DTB Editor) is joined by S...
AI and DTB, drug safety, tirzepatide, and lecanemab for Alzheimer's disease
In this podcast accompanying the August issue of DTB ( https://dtb.bmj.com/content/63/8 ), David Phizackerley (DTB Editor) is joined by Jame...
National asthma guidelines, bisoprolol for COPD and abaloparatide for osteoporosis
In this podcast accompanying the July issue of DTB ( https://dtb.bmj.com/content/63/7 ), David Phizackerley (DTB Editor) is joined by Syba S...
Identifying VTE in early pregnancy, gabapentinoids and COPD, managing ADHD
In this podcast accompanying the June issue of DTB, David Phizackerley (DTB Editor) is joined by Julian Treadwell (DTB Associate Editor) and...
The polypill revisited, cytisinicline for vaping cessation and a new co-host
In this podcast accompanying the May issue ( https://dtb.bmj.com/content/63/5 ) of DTB, David Phizackerley (DTB Editor) welcomes Syba Sunny...
Misuse of female empowerment to sell tests and treatments, triptan safety, use of ACEI or AIIRA in CKD
In this podcast recorded in early March, David Phizackerley (DTB Editor-in-Chief) and James Cave (DTB Editor-in-Chief Emeritus) provide an o...
Paying the price, liver problems with fezolinetant, systemic anticancer treatments
In this podcast recorded in early February, David Phizackerley and Julian Treadwell (DTB Associate Editor) provide an overview of the March...
Prioritising shared decision making, remission from type 2 diabetes, gefapixant for cough
In this podcast recorded in early January, David Phizackerley provides a brief overview of the February 2025 issue of DTB. The editorial dis...
PILs: all harms and no benefits, Irish College of GPs end pharma funding, Ryeqo for fibroids
In this podcast recorded in early December, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the January 2025...
When it comes to drugs, sex matters; menopausal HT and dementia; daridorexant for sleep
In this podcast recorded in early November, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the December issu...
Supporting obesity treatment, major bleeds with anticoagulants and SSRIs, equity in COPD care
In this podcast recorded in early October, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the November issue...
(Un)common sense in oncology, DOACs in device-detected AF, and hypertension in the elderly
In this podcast recorded in early September, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the October issu...
Medicines optimisation measures, warfarin-tramadol interaction and icosapent ethyl
In this podcast recorded in early August, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the September issue...
Psychotropic medicines in children, warfarin vs DOAC in old age, and fezolinetant in menopause
In this podcast recorded in early July, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) continue to ignore political and...